‘Extremely disappointed and surprised’: PharmaZen in receivership
The USX-listed nutraceutical company has accused BNZ Bank of refusing to meet with a major investor who wanted to recapitalise the business.
AiOra is PharmaZen/Waitaki’s branded product range of highly-functional, freeze-dried bovine organs and glands.
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
The board of USX-listed nutraceutical company PharmaZen has hit out at BNZ after the bank appointed receivers yesterday.
In a brief statement this morning, the board said it was “extremely surprised and disappointed” by the move and claimed that BNZ’s representative had refused to meet with
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Subscribe Now
Monthly Premium Online Subscription
NZ$49.95 / monthly
Subscribe Now
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Subscribe Now
Yearly Premium Online Subscription
NZ$499.00 / yearly
Subscribe Now
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly
credit card debit
Subscribe Now
Yearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Subscribe Now
Individual
Group membership
NBR Marketplace
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
